US Patent Issued to MedImmune on July 29 for "Polypeptides and uses thereof" (British Inventors)

ALEXANDRIA, Va., July 30 -- United States Patent no. 12,371,464, issued on July 29, was assigned to MedImmune Ltd. (Cambridge, Great Britain).

"Polypeptides and uses thereof" was invented by Maria Aleksandra Bednarek (Cambridge, Great Britain) and Sivaneswary Genapathy (Cambridge, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are polypeptides which are pramlintide analogues and uses thereof. In particular, the present invention relates to polypeptides of SEQ ID NO 2 which are pramlintide analogues conjugated to half-life extending moieties such as albumin binding moieties and uses thereof."

The patent was filed on Dec. 15, 2021, under Application No. 17/551,701.

*For further inform...